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PREFACE
My ultimate goal is to become an Epidemiologist, and Public Health
Educator/Humanitarian who focuses on reducing the mortality rates of breast and femalerelated carcinomas in low-income communities as well as low- and middle-income countries
(LMICs). Cancer epidemiology in women sparks my interest for various reasons. The first
being, I find it extremely interesting how carcinoma is known as a complicated chronic
disease due to the cancerous cells' intelligence in learning biochemical mechanisms and
creating an infinite number of pathways for invading healthy cells. The second and third
reasons correlate with one another. Both of my grandmothers had to receive breast
lumpectomies. One of my grandmother's cancer was invasive and she had to undergo
chemotherapy as a result. Even though they both survived, African American women are
faced with a more aggressive subtype of breast cancer than any other race or ethnicity, triplenegative breast cancer. I desire to be a part of the team who not only figures out why but
determines treatment alternatives. Lastly, women are the creators of life. I strongly support
the fact that health equity should be provided to those in need to combat the aggressive,
chronic disease that is slowly engulfing women in countries with low healthcare resources.
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ABSTRACT
Background. South African’s (SA) breast cancer incidence rate is continually increasing (39
per 100,000 (2012) versus 46.2 per 100,000 (2018) with trends towards later-stage diagnosis.
In previous literature, breastfeeding has been assessed as a protective factor for breast cancer;
however, the SA population experiences inconsistent breastfeeding trends, rates, and support
services. Therefore, this study will evaluate the inverse association between breast cancer and
breastfeeding history. Methods. Cases (breast cancer) and controls (mastalgia) were matched
1:1 on clinical visit from May-August 2019 at Groote Schuur Hospital (GSH) in Cape Town,
Western Cape, South Africa. Breastfeeding history, breast carcinoma diagnosis, and
clinically relevant endocrinology data was extracted from GSH medical records. Bivariate
conditional logistic regression (clogit) and 𝜒𝜒2 analyses compared predictor variables amongst
breast cancer groups. Multivariable clogit models assessed the association between breast

cancer diagnosis and breastfeeding history both unadjusted and adjusted for statistically and
clinically relevant confounders. Results. Results. In a sample of 360 SA mothers (mean age=
53 years old, SD= 14.36), 79% of breast cancer patients breast cancer breastfed while 75% of

non-breast cancer patients breastfed, with the majority of the population (75%) having everbreastfed overall. When controlling for all other covariates, SA mothers with breastfeeding
history did not have a lower risk of breast cancer compared to women who never breastfed
with OR=1.29 (95% CI 0.52 – 3.23). Conclusion. This pilot study did not show a protective
effect of breastfeeding on breast cancer diagnosis. However, it contributes to the theory that
race, ethnicity, and detailed exposure/outcome statuses are essential to concluding
statistically, biologically, and clinically significant results for the assessment of a doseresponse relationships.

TABLE OF CONTENTS
Abstract ................................................................................................................................... vii
List of Tables ............................................................................................................................. i
List of Figures ........................................................................................................................... ii
List of Appendices ................................................................................................................... iii
Introduction ................................................................................................................................1
Breastfeeding Benefits and Barriers ....................................................................................1
Breastfeeding Culture in South Africa .................................................................................3
Breastfeeding Rates in South Africa ....................................................................................5
Breastfeeding and Breast Cancer .........................................................................................9
Public Health Significance .......................................................................................................10
Breast Cancer and the South African Healthcare System ..................................................10
Specific Aim ............................................................................................................................11
Methods....................................................................................................................................13
Study Design ......................................................................................................................13
Study Setting ......................................................................................................................13
Study Subjects ....................................................................................................................14
Data Collection ..................................................................................................................15
Data Analysis .....................................................................................................................15
Human Subjects Safety Considerations ...................................................................................17
Ethical Considerations .......................................................................................................17
Results ......................................................................................................................................18
Sample Description ............................................................................................................18
Conditional Logistic Models..............................................................................................23
Discussion ................................................................................................................................26
Journal Article #1...............................................................................................................27

Title: Lactation and Breast Carcinoma Risk in a South African Population ...............27
Target Journal: American Cancer Society ...................................................................27
Journal Article #2...............................................................................................................29
Title: Prevalence of Comorbidities in Women with and Without Breast Cancer
in Soweto, South Africa: Results from the SABC study .......................................29
Target Journal: South African Medical Journal .................................................................29
Limitations .........................................................................................................................31
Conclusion ...............................................................................................................................32
Future Research .................................................................................................................32
Appendices ...............................................................................................................................33
References ................................................................................................................................34

LIST OF TABLES
Table 1: Description of Groote Schuur Hospital’s Breast Cancer Cases and Mastalgia
Controls Matched on Month of Clinical Visit .......................................................18
Table 2: Conditional Logistic Regression and 𝝌𝝌𝝌𝝌 Bivariate Analysis Comparing the
Difference Between Breast Cancer Groups Amongst Predictor Variables ...........21
Table 3: Unadjusted and Adjusted Conditional Odds of Breast Cancer with
Breastfeeding History, While Controlling for Statistically and Clinically
Relevant Covariates (i.e. Age at Clinical Visit and Family History of
Breast Cancer) ........................................................................................................23

i

LIST OF FIGURES
Figure 1: WHO Breastfeeding Recommendations Timeline .....................................................2
Figure 2: World Bank’s Data on South Africa Infant Mortality Rates (1974 – 2018) ..............3
Figure 3: High-Income Countries vs. Low- and Middle-Income Countries’ Overall
Breastfeeding Outlook Using 2018 UNICEF Data ..................................................6
Figure 4: High-, Middle-, and Low-Income Countries’ Breastfeeding Variation at 2
years of age ..............................................................................................................7
Figure 5: South Africa’s Demographic Transition Modeled From Our World Bank
1950 – 2015..............................................................................................................8
Figure 6: Predicted Probability of Breast Cancer with Breastfeeding History While
Controlling for Age ................................................................................................25
Figure 7: Predicted Probability of Breast Cancer with Family History of Breast
Cancer While Controlling for Age .........................................................................25

ii

LIST OF APPENDICES
Appendix A: Nestle` Formula Push Scandal Timeline ...........................................................33

iii

INTRODUCTION

Breastfeeding Benefits and Barriers
Breastfeeding is a natural and unique method of supplying infants with necessary
nutrition in their early life that cannot be replaced by any other nutritional item, including
infant formula, and encompasses health benefits for both the mother and baby (i.e. reduce
pediatric mortality and morbidity, benefit neurocognitive functions, and are less likely to
develop chronic diseases such as type 2 diabetes or become obese).1,2 To receive these
benefits, the World Health Organization (WHO) recommends 1) initiation of breastfeeding
within the first hour of birth 2) exclusive breastfeeding (EBF) for at least six-months 3)
complementary breastfeeding (CBF) up to two years of age and 4) breastfeeding on demand
(i.e. when the child wants).2,3

EBF is defined as solely supplying infants with breast milk for proper growth and
development since the milk will resource infants with 100% of the nutrients needed during
those recommended first six months of life.2 As indicated in Figure 1, after the first six
months of EBF, CBF is introduced and breast milk need not be used as the sole food-source,
but as an addendum to the introduction of solid foods and alternative drink options to the
infant's diet. It has been recommended that the consumption of breast milk in an older
infant's diet changes to 50% for the second six months of life, and 33% during the second
year of life.4
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Figure 1: WHO Breastfeeding Recommendations Timeline

Birth
- Breastfeeding
initiation
- EBF recommended

6 Months
- Introduction of CBF
- Breastfeeding
decreases to ~ 50%

Year 1
- CBF continues

Year 2
- CBF decreases
to 33%

Overall, in the United States (US), breastfeeding can prevent 823,000 child deaths
and boost the economy by approximately $300 billion (0.49% gross income improvement
globally). These health and fiscal benefits make breast milk superior to manufactured breast
milk substitutions (BMS) (i.e. infant formula). Therefore, BMS should be used as a tool, not
a precedence to EBF or CBF.5-8

Although breastfeeding has seemingly infinite number of benefits, complications and
frustrations can arise for the mother if their baby does not latch properly or if she is simply
unable to breastfeed. When available, donor milk is a substitute for mothers who are not able
to supply their children with their own breast milk for optimal nutrition.9 Therefore, mothers
can avoid the added expense of BMS which only provides secondary nutritional levels
compared to traditional breast milk. Donor milk is especially essential and practical during
instances where the infant is preterm or ill.9 When donor milk is not an available practice,
BMS can then be used to nourish the infant for adequate growth and development.

Conversely, the aggressive promotion and marketing associated with the BMS
industry has had a negative impact on overall breastfeeding practices. Unethical marketing
2

ploys in low- to middle- income countries (LMICs), including South Africa, by NestleTM
(Appendix A) caused mothers to live outside of their monetary means and purchase formula.
Mothers became hooked on the formula by creating goals of westernization and middle-class
acceptance. LMIC mothers were triggered to dilute their baby formula and inadvertently
deprive their baby of the necessary nutrients to stay alive, increasing infant mortality rates
(IMRs).10 As seen in Figure 2 and Appendix A, South Africa had their highest IMRs during
the NestleTM scandal allegations in the early to mid-1970s.11

Figure 2: World Bank’s Data on South Africa Infant Mortality Rates (1974 – 2018)
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Breastfeeding Culture in South Africa
South Africa is an LMIC which is harboring a substantial socioeconomic status (SES)
gap. Therefore, women who cannot afford manufactured BMS introduce additional foods and
3

drink, like maize porridge and water, to ensure their baby’s adequate nutrition (i.e. CBF).12-14
Moreover, the current WHO recommendation of EBF for at least six months does not align
with current South African breastfeeding practices. In a research study examining SA
mothers breastfeeding practices, none of the Peri-urban community mothers reported to EBF
their infants; however, 78% reported CBF practices.12

Sibeko et al. found other cultural beliefs such as the introduction of herbal
preparations (occurring in 56% of their study population) were responsible for several CBF
concerns.12 The mother's diet is ultimately the régime the infant will receive whether directly
or via breast milk. Hence, outside influences on the mother's decision-making (i.e., the
socioecological framework) must also be taken into consideration when understanding the
mother's decision to initiate breastfeeding, EBF, or CBF.

Generational knowledge and comprehension of breastfeeding mostly originates with
clinical figures. If physicians were misinformed or inadequately translating information to
patients, poor breastfeeding practices will recurrently circulate. Shah, Rollins, and Bland
found that despite 92% of doctors South Africa knowing initiation should take place within
30 minutes to one hour of delivery, other WHO recommendations such as EBF were not
mandated (i.e. 71% recommend water, 50% recommend solids, and 57% recommended
glucose water within the first six months of infancy).15 Difficulties associated with
breastfeeding initiation and exclusivity rates also arise when hospitals and clinical care teams
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are not breastfeeding-friendly environments (i.e. not initiating breastfeeding within the first
30 minutes to one hour of delivery or supplying baby formula).

South Africa is one of the most funded countries from President’s Emergency Plan
for AIDS Relief (PEPFAR).16 Conversely, there is conflicting and lack of translating
information to HIV-positive mothers regarding the transmission of HIV through breastmilk,
causing mixed feeding practices amongst infected mothers.17,18 During the early stages of the
HIV epidemic, infected mothers were generally discouraged from breastfeeding altogether if
they met certain South African mandated criteria to safely provide alternative methods to
nourish the infant.15 Many of the HIV-positive mothers did not meet said criteria. However,
HIV-infected mothers have been shown to at least initiate breastfeeding and were more likely
to initiate and report EBF compared to HIV-negative mothers.17, 19-21

Further research is required to assess prevention methods regarding female cancer
development and childhood ailments when comparing HIV-positive with HIV-negative
mothers. However, EBF has been shown to reduce the likelihood of HIV transmission from
mother to baby compared to CBF.22,23

Breastfeeding Rates in South Africa
Overall, despite low- (LIC), middle- (MIC), or high-income (HIC) status of a country,
the vast majority of children (95%) have ever been breastfed with trends of never
breastfeeding being lower in LICs and MICs (4%), like SA, compared to HICs (21%) (Figure
5

3).24 Although the general consensus is that LICs, MICs, and LMICs have higher
breastfeeding rates than HICs, breastfeeding rates and duration vary between and within
countries respective economic classifications. Nonetheless, the poorer the family, the higher
the likelihood of the mother and baby indirectly abiding by WHO breastfeeding
recommendations out of necessity to live within their means (Figure 4).25

Figure 3: High-Income Countries vs. Low- and Middle-Income Countries’ Overall
Breastfeeding Outlook Using 2018 UNICEF Data23
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Figure 4: High-, Middle-, and Low-Income Countries’ Breastfeeding Variation at 2 years of
age25

South Africa’s mortality and birth rates (Figure 5) indicate the country is undergoing
a phase in the demographic transition where developmental advancements are occurring
while birth and death rates are simultaneously decreasing.26,27 Westernization influences the
transformation of women’s roles in society into becoming more involved and having
7

increased responsibilities in the workplace. In response, breastfeeding practices have also
evolved.

The 2012 iteration of the South African Demographic and Health Survey (SADHS)
stated a decrease in breastfeeding duration (5.9 months) with 35.8% of children being
breastfeed for 12-15 months and 13.4% of children being breastfed for 20-23 months
compared to 2003’s SADHS reports a breastfeeding median of 16.6 months.28 SA
breastfeeding rates are highly dependent on the province and SES, as well as other factors
that are specific to South African municipals, like HIV status and overall breastfeeding
knowledge.

Figure 5: South Africa’s Demographic Transition Modeled from Our World Bank 1950
2015 Data26,27
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South Africa has shown fluctuating breastfeeding rates throughout its history. Women
have been reported to have very low EBF rates (7.4%) and high CBF (70-75%) rates before 6
months of age.28 These breastfeeding rates directly coincide with the diverse racial and ethnic
cultures which directly include breastfeeding practices within SA.12,15

Breastfeeding and Breast Cancer
Breastfeeding is known to have protective factors for the child who is consuming the
breast milk, but proper breastfeeding practices can also be a prevention method for the
mother as well. Health benefits include the risk reduction of estrogen-receptor (ER) related
cancers (such as ovarian and estrogen-receptor-positive (ER+) breast cancer) and the
prevention of 20,000 annual maternal-related breast cancer deaths in the US.4,6

Almost all breast cancer develops in the ducts or the lobules, developing a precancerous lesion, ductal carcinoma in situ or DCIS.29 During lactation, both health and
potentially damaged breast tissues are shed; thus, reducing the risk of breast cancer cell
development.30 Moreover, the longer a woman lactates and breastfeeds, the more breast tissue
cells will shed.

After 12 months, breastfeeding can slightly reduce the risk of both pre- and postmenopausal breast cancer by 4.3%.30,31 Mothers who breastfed for a combined duration of 2
years, for all children, are expected to attain about twice the benefit of those who breastfed
for a total of 1 year; whilst, mothers who breastfed for a lifetime total of more than two years
9

are expected to receive the most benefit with no significant difference for women in HICs
compared to LMICs.31,32

PUBLIC HEALTH SIGNIFICANCE

Breast Cancer and the South African Healthcare System

Breast carcinoma proliferative lesion of the breast tissue that has both genetic and
environmental risk factors, varying within each patient. South Africa (SA) is currently
experiencing increased rates of female cancers; specifically, breast carcinoma, with troubling
trends towards later-stage diagnoses. In 2012, southern Africa had an incidence of 39 breast
cancer cases per 100,000 women compared to 46.2 breast cancer cases per 100,000 women
2018.33,34 This increase was predicted by Globocan and is assumed to be caused by 1) all
forms of cancers are increasing in South Africa 2) healthcare resources are inadequate to
meet this growing need 3) breast cancer is the most common cancer amongst SA women 4)
most women in SA present with late-stage diagnoses.35-40

Metastasis and lymph node spread is the major concern with breast cancer; otherwise,
the disease can be mitigated, treated, and ultimately cured.41,42 The hindrance with later stage
diagnosis in SA is the higher probability of being diagnosed with metastatic breast cancer
and the inability to effectively treat or cure due to low resources; therefore, increasing the
mortality rate.41,42 The mortalities of non-communicable diseases, like cancers, are a result in
a shift away from pre-industrialization where infectious diseases are prominent, due to lack
10

of public health knowledge, and towards industrialization where chronic diseases are more
prevalent, due to increases in technology, more advanced medical practices, and
manufacturing.

Moreover, healthcare resources are being heavily allocated to the infectious disease
that are also burdening the SA healthcare system (i.e. tuberculosis (TB), human
immunodeficiency virus (HIV), and acquired immunodeficiency syndrome (AIDS)), so
breast cancer patients who are at risk of metastasis or who present with larger tumors at risk
of metastasizing may not receive as urgent care and management as desired.44,45

The proposed research aim, to evaluate the inverse association between breastfeeding
history and breast cancer outcomes, will provide quantitative evidence to support policy
decisions about how a low no-cost method (in terms of monetary value) may potentially aid
in the reduction of the foreseeable increase of breast cancer incidence which is burdening the
SA healthcare system. Using a method that is fiscally friendly is beneficial to LMICs like SA
because it will prevent additional economic strain. Instead, breastfeeding will indirectly
improve the economy because of breastfeeding’s additional healthcare benefits (i.e. reducing
childhood mortality/morbidity, childhood obesity prevention, infectious and chronic disease
prevention for both baby and mother).1,4,6
SPECIFIC AIM
Aim
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•

To evaluate the association between breastfeeding history and breast cancer diagnosis
while controlling for clinically and statistically relevant confounders (i.e. age,
enrollment date, breast cancer family history, HRT use, smoking ever-use, alcohol
consumption, HIV status, and menopausal status).

Hypothesis
•

There is an inverse association between breast cancer diagnosis and breastfeeding
exposure in South African mothers; while controlling for all other factors (i.e. age,
enrollment date, breast cancer family history, HRT use, smoking ever-use, alcohol
consumption, HIV status, and menopausal status).
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METHODS
Study Design

This pilot study implemented a hospital-based, nested case-control design. A
retrospective medical chart review was conducted and evaluated the association between
breastfeeding history (Y/N) of South African mothers in those who were diagnosed with
breast cancer (cases) or discharged with mastalgia (controls). The analysis controlled for
clinically and statistically relevant confounders including age, enrollment date, breast cancer
family history, HRT use, smoking ever-use, alcohol consumption, HIV status, and
menopausal status.

Data was collected from a public hospital in Cape Town, Western Cape, South Africa
during their Friday breast clinic where a combination of physician and pathology
examinations were conducted, Monday telephone clinic where pathology results were given
to patients from Friday’s breast clinic, and Wednesday Collaborative Breast Clinic (CBC)
where women’s breast cancer care plan was discussed.

Study Setting

Data was collected at Groote Schuur Hospital (GSH) located in Cape Town, Western
Cape, South Africa. GSH had a history of being a “Whites only” medical establishment
during the Apartheid era but is now a government-funded public hospital who accepts all
races, ethnicities, and patients with and without health insurance. Medical charts were
13

reviewed from patients who participated in the Friday breast clinic, Monday telephone clinic,
or Wednesday CBC.

Study Subjects

GSH’s Breast Ward patient population primarily consists of women who were coded
as H1, annual income < R36 000, of racial or ethnic origin, and deprived of health insurance.
Study participants were breast cancer patients at Groote Schuur Hospital from May-August
2019. Cases were diagnosed with breast cancer and required to meet the following inclusion
criteria: 1) diagnosed with breast cancer; 2) a mother; 3) participated in GSH’s Friday breast
clinic, Monday telephone clinic, or Wednesday CBC from May-August 2019; 4) female; 5)
African native or citizen.

Controls were defined as patients discharged with mastalgia and required to meet the
following inclusion criteria: 1) patients who present with mastalgia and were not diagnosed
with any other breast-related condition; 2) a mother; 3) participated in GSH’s Wednesday
CBC, Friday breast clinic, or Monday telephone clinic from May-August 2019; 4) female; 5)
African native or citizen.

Overall motherhood status was included in this study to avoid ethical implication that
may coincide with the title of a “mother”. Thus, this study also included patients who had
miscarriages or have children through another equivalent avenue. To avoid having a large
14

number of young women in the control group, patients were matched 1:1 on month of visit.
GSH had never had a patient under 20 years of age with breast cancer; therefore, the age
inclusion range was set at ≥ 20 years old. Potential control subjects who were diagnosed with
another benign diagnosis other than mastalgia were excluded from the study to avoid further
skew, residual confounding, and extensive effect measure modification.

Data Collection
The data collection for this study uses GSH’s Breast Clinic’s RedCapTM database to
collect cases and a retrospective medical chart review to collect controls. Cases and controls
were matched 1:1 on clinical visit to take into account the later-stage diagnosis trend. Data
were used to assess the association between breast cancer (outcome) and breastfeeding
history (exposure) as well as other covariates and potential confounding factors, including
age at clinical visit, breast cancer family history, HRT ever-use, smoking ever-use, alcohol
consumption, HIV status, and menopausal status. Data collection for this study did not
include personal health information or other identifiable factors.

Data Analysis

Univariate analysis including means and percentages were calculated to describe the
patient population by outcome status; mastalgia patients (controls), and breast cancer patients
(cases). Bivariate conditional logistic regression assessed the log odds difference in
15

continuous predictor variables (i.e. age at clinical visit, age of menarche, age at first delivery,
and number of pregnancies) betweeen non-breast cancer and breast cancer groups; while, 𝜒𝜒 2
analysis assess difference amongst categorical predictor variables (i.e. breastfeeding history,
breast cancer family history, HRT ever-use, HIV status, and menopausal status) between
non-breast cancer and breast cancer patient groups.

A crude model was initially constructed to assess the bivariate association between
the main exposure (breastfeeding history) and main outcome (breast cancer). Mid data
collection, medical forms were revised, removing alcohol consumption from the medical
history collection; therefore, alcohol was not considered in the multivariable model building
techniques due to inconsistent variability across the entire study period and population.
Forward and backward variable inclusion/elimination was used to build the multivariable
conditional logistic regression model. Both models had identical outcomes; therefore, AIC
numbers were not needed to be taken into account for the best fit model.

The final model resulted in age and age at first delivery being statically significant.
Due to multicollinearity between the two covariates, age at first delivery was removed,
leaving age to be controlled for in the adjusted model. Since family history and menopausal
status have genetic and clinical associations with breast cancer outcomes, respectively, both
predictor variables were considered for the multivariable model. However, age and
menopausal status were highly correlated, leaving age and family history to be controlled for
in the final multivariable conditional logistic regression model.
16

Effect measure modification was evaluated between age and family history using an
interaction term; however, a significant association was not observed. Predicted probabilities
of breast cancer was plotted against breastfeeding history and family history, across age
progression using post-estimation graphing techniques.

HUMAN SUBJECTS SAFETY CONSIDERATIONS

Ethical Considerations

Human Subjects ethics has been approved by the UTHealth Institutional Review
Board (HSC-SPH-19-0263) and Groote Schuur Hospital’s Ethics Committee (IRB number:
IRB00001938). All data were saved on a password-protected computer and were not
distributed to or viewed by any person that is not on either IRB application. No identifiers
were available in the dataset, neither individually, nor appended.
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RESULTS
Sample Description
Uni- and bivariate statistics of breast cancer cases and mastaglia discharged controls,
matched on month, are presented in Table 1. In a sample of 360 South African mothers, 77%
had a history of breastfeeding (main exposure) while 50% were diagnosed with breast cancer
(main outcome) due to the 1:1 matching on clinic visit month. The majority of the mothers
were not currently breastfeeding (99%) and post-menopausal (66%) which coincides with the
age (mean= 53, SD= 14.23) of the patient population. The average age of menarche was 14
(SD= 2.12), average age of delivery was 22 (SD= 5.10), and average number of pregnancies
was 3 (SD= 1.60). South African mothers also reported to have marginally higher
percentages of not having a family history of breast cancer (74%), no HRT ever-use (91%),
to be non-smoking (63%), consume no alcohol (83%), and were HIV-negative (91%).

Table 1: Description of Groote Schuur Hospital’s Breast Cancer Cases and Mastalgia
Controls Matched on Month of Clinical Visit
N= 360
N (%)

Age at Clinical Visit (mean, SD)

53, 14.14

Age of Menarche (mean, SD)

14, 2.12

Age at First Delivery (mean, SD)

22, 5.10

Number of Pregnancies (mean, SD)

3, 1.60

Breastfeeding History
(n=300)
No
18

69 (23)

Yes

231 (77)

No

226 (99)

Yes

3 (1)

No

242 (74)

Yes

87 (26)

No

145 (91)

Yes

14 (9)

No

201 (63)

Yes

118 (37)

No

182 (83)

Yes

38 (17)

Negative

236 (91)

Positive

16 (6)

Not Done

8 (3)

Currently Breastfeeding
(n=228)

Family History of Breast Cancer
(n=329)

HRT ever-use
(n=159)

Smoking ever-use
(n=319)

Alcohol Consumption
(n=220)

HIV status
(n=260)

Menopausal Status
(n=280)
Pre-menopausal

71 (26)

Peri-menopausal

21 (8)

19

Post-menopausal

185 (66)

Yes

180 (50)

No

180 (50)

Breast Cancer
(n=360)

Bivariate analyses of predictor variables, matched on month of clinic visit, compared
breast cancer and non-breast cancer diagnosed SA mothers (Table 2). The odds of breast
cancer significantly increased by 0.0267 with each increase year of age (p=0.016). The
statistical significance of age is visually represented by the mean age difference in non-breast
cancer (mean age 50, SD= 13.04) versus breast cancer (mean age 57, SD= 15.51) diagnoses.
There is also a statistical difference between HIV status amongst non-breast cancer and
breast cancer diagnoses. When SA mothers whose HIV test was “not done” were replaced as
missing, the statistical difference between positive and negative HIV status remained (p=
0.045). However, age of menarche (p=0.704), age at first delivery (p=0.259), number of
pregnancies (p= 0.961), currently breastfeeding (p=0.533), family history of breast cancer
(p=0.327), HRT ever-use (p= 0.567), smoking ever-use (p=0.063),

alcohol consumption

(p= 0.325), and menopausal status (p=0.433) showed no significance difference between
breast cancer and non-breast cancer groups.
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Table 2: Conditional Logistic Regression and 𝝌𝝌𝟐𝟐 Bivariate Analysis Comparing the Difference Between Breast Cancer Groups Amongst
Predictor Variables
N= 360
Clogit
Non-Breast
Breast
𝝌𝝌𝟐𝟐
Cancer

Cancer

(𝜷𝜷, p-value)

Age at Clinical Visit (mean, SD)

50, 13.04

57, 15.51

0.0267, 0.016 *

Age of Menarche (mean, SD)

14, 2.13

13, 0

- 0.275, 0.704

Age at First Delivery (mean, SD)

22, 4.78

23, 5.35

0.040, 0.259

Number of Pregnancies (mean, SD)
Breastfeeding History
(n=300)

3, 1.55

3, 1.65

0.005, 0.961

p-value

0.358
No
Yes

39 (25)
116 (75)

30 (21)
115 (79)

Currently Breastfeeding
(n=228)

0.533
No
Yes

71 (99)
1 (1)

155 (99)
1 (1)

Family History of Breast Cancer
(n=329)

0.327
No
Yes

120 (71)
48 (29)

122 (76)
39 (24)

HRT ever-use
(n=159)

0.567
No

84 (92)

61 (90)
21

Yes

7 (8)

7 (10)

Smoking ever-use
(n=319)

0.061
No
Yes

94 (58)
68 (42)

107 (68)
50 (32)

Alcohol Consumption
(n=220)

0.325
No
Yes

68 (86)
11 (14)

114 (81)
27 (19)

HIV status
(n=260)

< 0.0001*
Negative
Positive
Not Done

148 (91)
14 (9)
0 (0)

88 (90)
2 (1)
8 (8)

Menopausal Status
(n=280)

0.413
Pre-menopausal
Peri-menopausal
Post-menopausal

41 (30)
11 (8)
86 (62)

33 (23)
10 (7)
99 (70)

SD= standard deviation; 𝝌𝝌𝟐𝟐 = chi-square; 𝜷𝜷= beta coefficient; clogit= conditional logistic regression
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Conditional Logistic Models

A bivariate conditional logistic regression model, grouped by month of clinic visit,
was conducted to examine the crude odds of breast cancer diagnosis with breastfeeding
history (Table 3). Breastfeeding is shown to have a positive association that is not
statistically significant (OR= 1.50, 95% CI [0.71 – 3.16]). Therefore, although not
statistically significant, South African mothers who have a history of breastfeeding have a
50% higher odds of breast cancer compared to South African mothers who do not have a
history of breastfeeding.

Table 3: Unadjusted and Adjusted Conditional Odds of Breast Cancer with Breastfeeding
History, While Controlling for Statistically and Clinically Relevant Covariates (i.e. Age at
Clinical Visit and Family History of Breast Cancer)
Model 1
OR (95% CI)

Model 2
AOR (95% CI)

Ref
1.50 (0.71 – 3.16)
---

Ref.
1.54 (0.69 – 3.43)

----0.0051

Ref.
1.04 (0.49 – 2.22)
0.0400

Breastfeeding History
No
Yes
Age at Clinical Visit

1.03 (1.01 – 1.06)

Family History of Breast Cancer
No
Yes
R2

OR= unadjusted odds ratio; AOR= adjusted odds ratio; CI= confidence interval; age is measured in years; Ref.=
reference group

Model 2 in Table 3 contains statistically relevant confounders (i.e. age) in addition
to family history which is clinically relevant effect measure modifiers for breast cancer
23

outcomes. Although not statistically significant, the increased odds of breast cancer with
breastfeeding history increased from 50% in the crude model to 54% (AOR= 1.54, 95% CI
[0.69 – 3.43]) in the adjusted model when controlling for age at clinical visit and family history
of breast cancer. In addition, SA mothers with a family history of breast cancer have 4% higher
odds of being diagnosed with breast cancer (AOR= 1.04, 95% CI [0.49 – 2.22]), when
controlling for breastfeeding and age at clinical visit. With each yearly increase in age, the
odds of breast cancer significantly increased by 3% (AOR= 1.05, 95% CI [1.01 – 1.06]), when
controlling for breastfeeding and family history of breast cancer.

The graphic display of the association between breastfeeding history and breast
cancer diagnosis while controlling for age (Figure 7) shows an increased predicted probability
as age increases. The overlap in the confidence intervals for both breastfeeding exposure
categories (Y/N) represents the non-statistical significance of the association between the main
exposure (breastfeeding history) and main outcome (breast cancer diagnosis). Figure 8 shows
a different result where family history differences were not affected by age, but also had an
increased breast cancer outcome and confidence interval overlap between exposure groups,
illustrating the non-statistically significant from the 4% increased odds of breast cancer
diagnosis.
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Figure 6: Predicted Probability of Breast Cancer with Breastfeeding History While Controlling
for Age

Figure 7: Predicted Probability of Breast Cancer with Family History of Breast Cancer While
Controlling for Age
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DISCUSSION

In this retrospective, nested case-control study that examined the association between
breastfeeding history and breast cancer, results did not support a protective effect.
Specifically, when assessing the direct relationship between breastfeeding history and breast
cancer, South African mothers who have a history of breastfeeding have a 50% increase in
odds of breast cancer compared to South African mothers who have no history of
breastfeeding. The adjusted conditional logistic regression model also resulted in a positive
relationship opposed to the hypothesized inverse association. When controlling for age at
clinical visit and family history of breast cancer, South African mothers who have a history
of breastfeeding have a 54% increased odds of breast cancer compared to not having a
breastfeeding history. In favor of the unique characteristics within the patient population,
neither of the cross-over effects were supported by previous literature outside of the South
Africa setting, but is similar to literature that the same patient population attributes.
Additionally, there is evidence of negative confounding by family history and age because of
their influence in the odds of breast cancer in the adjusted model (Table3).

This positive association may be due to the limitations associated with the study in
the design phase. The true inverse association between breastfeeding history and breast
cancer odds could be hidden in light of residual confounding caused by race and ethnicity in
addition to detailed breastfeeding history. However, age (3%) and family history (4%) have
long been shown to be associated with increased odds of breast cancer diagnoses in previous
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studies and are well-established causal risk factors which is also supported in this research
study.46-53

Breast cancer and modern treatment methods are stigmatized in African communities.
Therefore, information bias from recall and interviewer bias (i.e. patients hiding information)
during the verbal genetic mapping process that is conducted in the SA healthcare system may
be the source of the lack of statistical significance when assessing the association between
family history and breast cancer outcomes.54,55 Further research such as a qualitative study
identifying themes and patterns in patients who undergo genetic testing, in addition to the
physicians who conduct the genetic testing would need to be conducted to further isolate and
assess the non-significant association.

Journal Article #1
Title: Lactation and Breast Carcinoma Risk in a South African Population
Target Journal: American Cancer Society
Demographically, most of South African women within the study sample (446 cases,
1471 controls) were defined as “colored” and between 35-49 years of age. Furthermore, the
majority of the population in both cases (83%) and controls (85%) had a history of
breastfeeding (OR = 0.9, 95% CI [0.7-1.3]). However, cases had a higher age at first delivery
(20-24 (47.7%)) compared to controls (<20 (43.6)).56
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Concerning the effects of lactation duration and history on breast carcinoma
diagnosis, results concluded all breastfeeding odds were close to or equivalent to having a
null effect for those who had accumulated a total breastfeeding period of less than three years
(i.e. never (Ref.), ever (OR= 0.9 [0.7 – 1.3]), < 1 year (OR= 0.9 [0.6 – 1.3]), 1 year (OR= 1.1,
[0.7 – 1.6]), 2 years (OR= 1.0, [0.6 – 1.5])).56 Conversely, SA mothers who had a life-course
of breastfeeding time of more than three years had a protective effect, although not
statistically significant (i.e. 3-4 years (OR= 0.8 [0.5 – 1.2]), 5-6 years (OR+ 0.8, [0.5 – 1.4]),
≥ 7 years (OR= 0.7, [0.4 – 1.3]).56

The covariates of menopausal status (i.e. never (Ref.); ever (OR= 1.0 [ 0.7 – 1.4]),
number of children (i.e. none (Ref.), 1 (OR= 0.9, [0.6 – 1.3]), 2 (OR= 0.9 [0.6 – 1.3]), 3
(OR= 1.0, [0.6, 1.5]), 4 (OR= 1.0, [0.6 – 1.6]), 5 (OR= 1.3, [0.7 – 2.3])), and age at fist
lactation (i.e. never (Ref.), ≤ 18 (OR= 0.7 [0.5 – 1.1]), 19 – 20 (OR= 0.8 [0.6 – 1.2]), 21 – 24
(OR= 1.0, [0.7 – 1.4]), 25 – 29 (OR= 1.1, [0.8 – 1.7]), ≥ 30 (OR= 1.2, [0.7 – 2.1])) were also
observed to have a null effect on breast cancer odds.56

Both this research study and Coogen et al.’s study was conducted in the form of a
hospital-based, case-control design. However, Coogen et al. did not use a defined cohort for a
nested case-control study design. The patient populations were similar in the sense that
majority of women in both samples of mothers ever breastfed and the difference amongst
breastfeeding groups were not statistically significant (i.e. 83% cases and 85% controls (OR
= 0.9, 95% CI [0.7-1.3]) in Coogen et al. versus 79% cases and 75% controls (p= 0.358)).56
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While both research studies failed to obtain an inverse association between
breastfeeding exposure and breast cancer outcomes, this study resulted in a cross-over effect
while Coogen et al.’s research study concluded a null effect respective to WHO guidelines
(AOR= 1.54, 95% CI [0.69 – 3.43]; (1 year (OR= 1.1, [0.7 – 1.6], respectively).56 The
difference in concluding a null versus a positive association may be because Coogen et al.’s
was able to obtain more detailed breastfeeding information (i.e. lactation duration). However,
neither study was able to collect exclusivity versus complementary breastfeeding data which
is essential is observing protective effects of breast milk for mothers.

Additionally, neither study included race and ethnicity in their final logistic model.
This research study was not able to collect said data points while Coogen et al. omitted the
variable due to ambiguity regarding the definition of the racial and ethnic terms used in
South Africa. In addition, this study was also not able to collect breastfeeding duration
information. Therefore, there may be residual confounding in both studies due to race,
ethnicity, and more specific breastfeeding history data points.

Journal Article #2
Title: Prevalence of Comorbidities in Women with and Without Breast Cancer in
Soweto, South Africa: Results from the SABC study
Target Journal: South African Medical Journal
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The research study observing the effects of comorbidities on breast cancer was
conducted in a matched case-control design. The 798 Black, South African women who
participated in this study (mean age= 54.6, SD= 12.9) were categorized into two groups 1)
advanced stage breast cancer cases 2) age and neighborhood match non-breast cancer
controls.57 Similar to this research study, majority of the population in Ayeni et al.’s study
was HIV-negative (i.e. 90% cases and 91% controls versus 83.5% cases and 77.4% controls,
respectively).57

Women with HIV had a significantly higher odds of presenting with advanced stage
breast cancer compared to women without HIV (OR= 1.75, 95% CI [1.01 – 2.99]).57
Furthermore, women who were HIV-positive have 1.44 [0.80 – 2.57] times the odds of
presenting with advanced stage breast cancer compared to women who were HIV-negative,
when controlling for age, household income, dyslipidemia, and hypertension.57

While Ayeni et al.’s study does not examine lactation history, it does take into
account the effects of HIV on breast cancer. Comparable to Ayeni et al.’s study (p=0.032),
this study observed a statistical difference (p= < 0.001) amongst HIV groups (negative,
positive, not done) between breast cancer and non-breast cancer.57 However, HIV was
considered in the final model of this study due to lack of statistical significance. Therefore,
the impact of HIV on breast cancer odds was not observed.57
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Limitations

The theorized association between breastfeeding and the reduced risk of breast cancer
has been studied for decades. The inverse association is a result of ovulation suppression
from lactation, which lowers estrogen levels and suppresses the food supply of ER+ breast
cancers. Also, when mothers breastfeed, they shed breast tissue cells, including those that
may be cancerous. Therefore, lactation duration is an important aspect when considering the
reduced risk of breast cancer. Critical data collection elements were not collected to make the
inverse association between breastfeeding history and breast cancer (i.e. breastfeeding
duration, initiation, exclusivity, and complementary).

The original study protocol was modified to a retrospective format for GSH Ethics
Committee approval; therefore, eliminating the ability to collect detailed breastfeeding data
along with accompanying qualitative interviews with staff and patients regarding the SA
healthcare system. Collection of race and ethnicity data was also rejected and caused cultural
interpretations and genetic dissimilarities about breastfeeding effects and practices to be
combined; thus, leaving room for ambiguity in breastfeeding history and constituting
variability. In addition, there are research gaps regarding the inverse association between
breast carcinoma and lactation in South African women; nonetheless, previous studies in a
South African failed to form an inverse relationship. Stratifying breastfeeding history and
endocrinology data by race, ethnicity, and breastfeeding category, would enhance the
comprehension of South African breastfeeding culture, effects, and breast cancer burden.
31

CONCLUSION
Although the inverse association between breastfeeding history and breast cancer
outcome was not observed, this pilot study provides credible research in support of the
evidence-based theory that race, ethnicity, and detailed exposure-outcome status information
is vital when observing the association of chronic diseases. Especially when dealing with
scopes of practices and subject matters like cancers which is affected by a combination of
genetic, environmental, and behavioral practices.

Future Research
There are significant gaps in the field regarding South African women and breast
carcinoma overall. Innovative solutions to the limitations of this study may include: a
multidisciplinary team consisting of SA surgical leaders, oncologists, and physicians within
the breast and OBGYN wards, where data collection will occur, will collaborate on the study
protocol. New chart forms will be curated to include breastfeeding details (initiation,
duration, exclusivity, and complimentary) within the present endocrinology subsection to
ease data collection processes, especially considering multiple languages (i.e. Afrikaans,
Xhosa, and English). World Health Organization (WHO) breastfeeding regulations will be
used for consistent and accurate recordings. Qualitative methods will also need to be
included in a future study to better understand the patient population for appropriately
tailored data collection procedures and, if needed, intervention programs.
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APPENDICES
Appendix A: Nestle` Formula Push Scandal Timeline10
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